Verita Healthcare Group has announced three digital healthcare investments as part of its international expansion and consolidation strategy.
The acquisitions underline Verita’s aim to be one of the world’s leading integrative healthcare companies. The announcement coincides with the recent establishment of the company’s European headquarters in London, which will act as a strategic base alongside its US headquarters in Silicon Valley and Asian headquarters in Singapore.
Each business provides a range of customisable tools aligned with Verita’s aim to help people take control of their health and wellbeing through providing a range of cost effective, personalised digitally-enabled solutions:
- nBuddy is a chronic disease management (“CDM”) app focused on helping people with chronic illnesses – such as obesity, diabetes and hypertension – to manage and reverse their health issues. Its digital intervention programs, including expert nutritional and lifestyle advice and coaching, have been developed in Singapore to specifically cater for the huge Asia market.
- CelliHealth is a digital health and wellness platform for employers and insurers, providing healthy lifestyle education, gamified challenges, activity tracking, and incentives for hitting healthy lifestyle and wellness goals.
- Hanako provides a range of market-leading, real-time, AI-driven mobile health screening solutions onsite for employees of large corporates in Germany.
In line with its ambitions, Verita is building a world-leading, multi-faceted digital platform for mass transformational health.
The three investments will be incorporated into the Verita Wisdom platform, which offers people a range of tools to enable the early detection, prevention, management and reversal of the chronic diseases that drive over 70% of all global deaths and healthcare spend.
Julian Andriesz, Founder, Verita Healthcare Group, commented, “These targeted investments fit well with our long-term goal for Verita. We have a strong acquisition and partnership strategy which has seen Verita Wisdom grow quickly over the last 18 months. We plan to make more investments in the near future which will result in Verita Wisdom becoming the largest and best digital health platform in the world in terms of user base, services, geographical reach, proven outcomes and profitability.
“With each acquisition we look for a proposition that adds value to our clients, providing greater choice and smarter technology, as well the ability to integrate with our current services. With CelliHealth, nBuddy and Hanako we’ll be able to help more users take greater control of their health.
“The integration of these platforms under Verita Wisdom complements the Group’s other services, which include treatment and product manufacturing centres around the world, making proactive healthcare more accessible than ever.
